Songthip Ounpraseuth
Concepts (383)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Ultrasonography, Prenatal | 10 | 2021 | 188 | 2.380 |
Why?
| Amniotic Fluid | 9 | 2020 | 108 | 2.240 |
Why?
| Heart Failure | 8 | 2022 | 458 | 1.830 |
Why?
| Pregnancy | 41 | 2023 | 2607 | 1.370 |
Why?
| Neonatal Abstinence Syndrome | 6 | 2024 | 25 | 1.270 |
Why?
| Fetal Membranes, Premature Rupture | 5 | 2021 | 22 | 1.240 |
Why?
| Cocaine-Related Disorders | 6 | 2019 | 205 | 1.180 |
Why?
| Female | 83 | 2024 | 26472 | 1.120 |
Why?
| Oligohydramnios | 6 | 2020 | 60 | 1.070 |
Why?
| Humans | 102 | 2024 | 49974 | 0.940 |
Why?
| Stereotyping | 3 | 2019 | 33 | 0.920 |
Why?
| Religion | 2 | 2014 | 63 | 0.890 |
Why?
| Insurance, Health | 3 | 2019 | 126 | 0.850 |
Why?
| Infant, Newborn | 22 | 2024 | 2772 | 0.840 |
Why?
| Attitude of Health Personnel | 5 | 2022 | 347 | 0.820 |
Why?
| Quality of Life | 6 | 2020 | 836 | 0.820 |
Why?
| Health Personnel | 4 | 2020 | 246 | 0.790 |
Why?
| Advance Directives | 3 | 2023 | 29 | 0.780 |
Why?
| Substance-Related Disorders | 7 | 2019 | 600 | 0.760 |
Why?
| Caregivers | 2 | 2022 | 208 | 0.750 |
Why?
| Adult | 43 | 2024 | 13236 | 0.750 |
Why?
| Placenta Accreta | 1 | 2021 | 25 | 0.740 |
Why?
| Health Knowledge, Attitudes, Practice | 5 | 2022 | 488 | 0.730 |
Why?
| Length of Stay | 4 | 2024 | 619 | 0.710 |
Why?
| Pregnancy Complications | 6 | 2023 | 382 | 0.710 |
Why?
| Rural Population | 13 | 2022 | 540 | 0.710 |
Why?
| Medicaid | 6 | 2023 | 257 | 0.680 |
Why?
| Patient Preference | 1 | 2019 | 36 | 0.660 |
Why?
| Delivery, Obstetric | 5 | 2020 | 122 | 0.630 |
Why?
| Middle Aged | 31 | 2024 | 12069 | 0.630 |
Why?
| Mentally Ill Persons | 1 | 2018 | 14 | 0.620 |
Why?
| Arkansas | 17 | 2022 | 1977 | 0.620 |
Why?
| Prejudice | 1 | 2018 | 40 | 0.620 |
Why?
| Obstetrics | 4 | 2022 | 88 | 0.610 |
Why?
| Premature Birth | 5 | 2021 | 147 | 0.600 |
Why?
| Gestational Age | 11 | 2022 | 421 | 0.600 |
Why?
| Stillbirth | 3 | 2022 | 29 | 0.590 |
Why?
| Male | 41 | 2024 | 25241 | 0.580 |
Why?
| Analgesics, Opioid | 7 | 2024 | 552 | 0.580 |
Why?
| Sexual Behavior | 2 | 2017 | 117 | 0.570 |
Why?
| Retrospective Studies | 25 | 2022 | 6108 | 0.560 |
Why?
| Placenta | 5 | 2022 | 132 | 0.550 |
Why?
| Hospitals | 2 | 2020 | 175 | 0.540 |
Why?
| Telemedicine | 5 | 2022 | 448 | 0.520 |
Why?
| Depression | 6 | 2019 | 568 | 0.520 |
Why?
| Hospitalization | 2 | 2017 | 652 | 0.520 |
Why?
| Pregnancy Outcome | 7 | 2021 | 237 | 0.500 |
Why?
| Inpatients | 1 | 2016 | 190 | 0.500 |
Why?
| Cesarean Section | 5 | 2021 | 187 | 0.490 |
Why?
| United States | 20 | 2024 | 4860 | 0.470 |
Why?
| Intensive Care Units, Neonatal | 4 | 2020 | 115 | 0.470 |
Why?
| Depressive Disorder | 1 | 2016 | 339 | 0.460 |
Why?
| Advance Care Planning | 2 | 2024 | 19 | 0.450 |
Why?
| United States Department of Veterans Affairs | 5 | 2024 | 285 | 0.450 |
Why?
| Infant, Premature, Diseases | 1 | 2014 | 94 | 0.440 |
Why?
| Veterans | 3 | 2024 | 555 | 0.430 |
Why?
| Vitamin D Deficiency | 2 | 2023 | 44 | 0.420 |
Why?
| Healthcare Disparities | 3 | 2022 | 257 | 0.420 |
Why?
| Monte Carlo Method | 1 | 2012 | 84 | 0.420 |
Why?
| Vaccines | 2 | 2023 | 50 | 0.420 |
Why?
| Quality Indicators, Health Care | 3 | 2017 | 86 | 0.410 |
Why?
| Infant, Very Low Birth Weight | 1 | 2012 | 48 | 0.400 |
Why?
| Aged | 19 | 2024 | 9310 | 0.400 |
Why?
| Infant Mortality | 1 | 2012 | 60 | 0.400 |
Why?
| Longitudinal Studies | 7 | 2020 | 688 | 0.390 |
Why?
| Research Design | 5 | 2022 | 344 | 0.380 |
Why?
| Polyhydramnios | 4 | 2019 | 31 | 0.370 |
Why?
| Medical Records | 2 | 2022 | 83 | 0.370 |
Why?
| Young Adult | 15 | 2021 | 3958 | 0.350 |
Why?
| Blood Transfusion | 2 | 2021 | 121 | 0.350 |
Why?
| Kidney Neoplasms | 2 | 2022 | 177 | 0.340 |
Why?
| Mental Disorders | 3 | 2019 | 396 | 0.340 |
Why?
| Birth Weight | 5 | 2020 | 120 | 0.340 |
Why?
| Mental Health Services | 3 | 2019 | 198 | 0.340 |
Why?
| Hair Color | 1 | 2009 | 10 | 0.340 |
Why?
| Asthma | 2 | 2023 | 281 | 0.340 |
Why?
| Algorithms | 1 | 2012 | 615 | 0.330 |
Why?
| Adolescent | 13 | 2023 | 6356 | 0.320 |
Why?
| Congenital Abnormalities | 2 | 2021 | 112 | 0.320 |
Why?
| Gynecology | 2 | 2022 | 49 | 0.310 |
Why?
| Labor Stage, Third | 2 | 2018 | 19 | 0.310 |
Why?
| Predictive Value of Tests | 3 | 2019 | 903 | 0.310 |
Why?
| Postpartum Hemorrhage | 2 | 2018 | 34 | 0.300 |
Why?
| Image Processing, Computer-Assisted | 1 | 2009 | 242 | 0.300 |
Why?
| Viscosupplements | 2 | 2017 | 14 | 0.290 |
Why?
| Fatigue | 2 | 2019 | 117 | 0.290 |
Why?
| Hyaluronic Acid | 2 | 2017 | 34 | 0.290 |
Why?
| Data Collection | 4 | 2022 | 279 | 0.290 |
Why?
| Obesity, Morbid | 2 | 2018 | 78 | 0.290 |
Why?
| Perinatal Care | 2 | 2020 | 26 | 0.280 |
Why?
| Adrenal Cortex Hormones | 2 | 2017 | 94 | 0.280 |
Why?
| Osteoarthritis, Knee | 2 | 2017 | 88 | 0.270 |
Why?
| Opioid-Related Disorders | 2 | 2023 | 381 | 0.270 |
Why?
| Logistic Models | 5 | 2017 | 888 | 0.260 |
Why?
| Hypertension | 2 | 2021 | 533 | 0.260 |
Why?
| Dye Dilution Technique | 3 | 2014 | 18 | 0.250 |
Why?
| Schizophrenia | 2 | 2018 | 256 | 0.250 |
Why?
| Internship and Residency | 2 | 2022 | 443 | 0.250 |
Why?
| Breast Neoplasms | 1 | 2012 | 1174 | 0.220 |
Why?
| Alcohol Drinking | 3 | 2015 | 224 | 0.220 |
Why?
| Time Factors | 9 | 2023 | 2903 | 0.220 |
Why?
| Social Support | 3 | 2022 | 263 | 0.220 |
Why?
| Databases, Factual | 3 | 2020 | 658 | 0.210 |
Why?
| Randomized Controlled Trials as Topic | 5 | 2023 | 549 | 0.210 |
Why?
| Pregnant Women | 1 | 2023 | 77 | 0.210 |
Why?
| Pharmacies | 1 | 2023 | 61 | 0.210 |
Why?
| Health Services Accessibility | 3 | 2019 | 398 | 0.210 |
Why?
| Labor, Obstetric | 2 | 2020 | 45 | 0.210 |
Why?
| Medicare | 2 | 2022 | 246 | 0.200 |
Why?
| Substance Withdrawal Syndrome | 1 | 2023 | 169 | 0.200 |
Why?
| Peripartum Period | 1 | 2022 | 15 | 0.200 |
Why?
| Prescription Drugs | 1 | 2022 | 38 | 0.200 |
Why?
| Blood Volume | 2 | 2019 | 68 | 0.200 |
Why?
| Nurses | 1 | 2022 | 49 | 0.200 |
Why?
| Hypertension, Pregnancy-Induced | 1 | 2022 | 16 | 0.200 |
Why?
| Occupational Health | 1 | 2022 | 68 | 0.200 |
Why?
| Prospective Studies | 8 | 2023 | 2364 | 0.200 |
Why?
| Motor Activity | 2 | 2013 | 229 | 0.200 |
Why?
| Burnout, Professional | 1 | 2022 | 51 | 0.200 |
Why?
| Community Health Workers | 1 | 2021 | 50 | 0.190 |
Why?
| Infant | 6 | 2024 | 3567 | 0.190 |
Why?
| Hydroxyprogesterones | 1 | 2021 | 8 | 0.190 |
Why?
| Pregnancy Complications, Hematologic | 1 | 2021 | 15 | 0.190 |
Why?
| Carcinoma, Renal Cell | 1 | 2022 | 105 | 0.190 |
Why?
| Phenobarbital | 1 | 2021 | 17 | 0.190 |
Why?
| Reference Values | 2 | 2019 | 310 | 0.190 |
Why?
| Clonidine | 1 | 2021 | 26 | 0.190 |
Why?
| HIV Infections | 2 | 2015 | 357 | 0.190 |
Why?
| Diabetes, Gestational | 1 | 2021 | 53 | 0.190 |
Why?
| Cross-Sectional Studies | 6 | 2023 | 1557 | 0.190 |
Why?
| Hysterectomy | 1 | 2021 | 88 | 0.190 |
Why?
| Parturition | 4 | 2023 | 49 | 0.190 |
Why?
| Hospitals, Teaching | 1 | 2020 | 53 | 0.180 |
Why?
| Amnion | 1 | 2020 | 11 | 0.180 |
Why?
| Morphine | 1 | 2021 | 103 | 0.180 |
Why?
| Feasibility Studies | 5 | 2022 | 375 | 0.180 |
Why?
| Neonatology | 1 | 2020 | 13 | 0.180 |
Why?
| Self Efficacy | 2 | 2018 | 129 | 0.180 |
Why?
| Palliative Care | 1 | 2022 | 187 | 0.180 |
Why?
| Infant, Small for Gestational Age | 1 | 2020 | 34 | 0.180 |
Why?
| Education, Medical | 1 | 2022 | 112 | 0.180 |
Why?
| Analgesics | 1 | 2021 | 100 | 0.180 |
Why?
| Labor, Induced | 2 | 2020 | 25 | 0.180 |
Why?
| Pharmacists | 2 | 2011 | 144 | 0.180 |
Why?
| Pregnancy in Diabetics | 1 | 2020 | 31 | 0.170 |
Why?
| Sex Factors | 3 | 2019 | 691 | 0.170 |
Why?
| Anemia, Sickle Cell | 1 | 2021 | 96 | 0.170 |
Why?
| Psychotherapy | 2 | 2017 | 104 | 0.170 |
Why?
| Pilot Projects | 5 | 2022 | 699 | 0.170 |
Why?
| Primary Health Care | 2 | 2022 | 358 | 0.170 |
Why?
| Pre-Eclampsia | 2 | 2017 | 55 | 0.170 |
Why?
| Risk Reduction Behavior | 2 | 2017 | 59 | 0.170 |
Why?
| Social Stigma | 2 | 2019 | 47 | 0.170 |
Why?
| Propensity Score | 3 | 2017 | 123 | 0.170 |
Why?
| Fetus | 1 | 2020 | 217 | 0.170 |
Why?
| Cohort Studies | 6 | 2020 | 1422 | 0.170 |
Why?
| Patient Care Team | 1 | 2021 | 254 | 0.170 |
Why?
| Blood Specimen Collection | 1 | 2019 | 34 | 0.170 |
Why?
| Medical Errors | 1 | 2019 | 24 | 0.160 |
Why?
| Fetal Blood | 1 | 2019 | 68 | 0.160 |
Why?
| Community-Based Participatory Research | 2 | 2018 | 199 | 0.160 |
Why?
| Education, Distance | 1 | 2019 | 40 | 0.160 |
Why?
| Sodium, Dietary | 1 | 2018 | 26 | 0.160 |
Why?
| Holistic Health | 1 | 2018 | 7 | 0.160 |
Why?
| Meditation | 1 | 2018 | 9 | 0.150 |
Why?
| Amphetamine-Related Disorders | 1 | 2019 | 94 | 0.150 |
Why?
| Aged, 80 and over | 4 | 2020 | 3129 | 0.150 |
Why?
| Surgical Wound Dehiscence | 1 | 2017 | 21 | 0.150 |
Why?
| Job Satisfaction | 2 | 2022 | 35 | 0.150 |
Why?
| Monitoring, Ambulatory | 1 | 2017 | 8 | 0.150 |
Why?
| Ultrasonography, Doppler, Color | 1 | 2017 | 33 | 0.150 |
Why?
| Medication Adherence | 1 | 2018 | 128 | 0.140 |
Why?
| Mandatory Programs | 1 | 2017 | 23 | 0.140 |
Why?
| Remote Consultation | 1 | 2017 | 29 | 0.140 |
Why?
| Condoms | 1 | 2017 | 22 | 0.140 |
Why?
| Physicians | 1 | 2020 | 233 | 0.140 |
Why?
| Focus Groups | 1 | 2018 | 190 | 0.140 |
Why?
| Respiratory Distress Syndrome, Newborn | 1 | 2017 | 52 | 0.140 |
Why?
| Aftercare | 1 | 2017 | 75 | 0.140 |
Why?
| Surgical Wound Infection | 1 | 2017 | 115 | 0.140 |
Why?
| Pregnancy, High-Risk | 2 | 2017 | 60 | 0.140 |
Why?
| Diabetes Mellitus | 1 | 2020 | 285 | 0.140 |
Why?
| Arthroplasty, Replacement, Knee | 2 | 2017 | 282 | 0.130 |
Why?
| Postpartum Period | 1 | 2017 | 113 | 0.130 |
Why?
| Stress, Psychological | 1 | 2018 | 260 | 0.130 |
Why?
| Behavior Therapy | 1 | 2017 | 181 | 0.130 |
Why?
| Insurance Coverage | 1 | 2017 | 103 | 0.130 |
Why?
| Patient Satisfaction | 1 | 2017 | 273 | 0.130 |
Why?
| Health Education | 1 | 2017 | 156 | 0.130 |
Why?
| Autistic Disorder | 1 | 2017 | 119 | 0.130 |
Why?
| Body Weight | 2 | 2017 | 513 | 0.130 |
Why?
| Body Mass Index | 4 | 2020 | 652 | 0.120 |
Why?
| Sexually Transmitted Diseases, Viral | 1 | 2014 | 8 | 0.120 |
Why?
| Health Promotion | 1 | 2017 | 271 | 0.120 |
Why?
| Risk Assessment | 1 | 2019 | 1259 | 0.120 |
Why?
| Fetal Weight | 1 | 2014 | 12 | 0.120 |
Why?
| Fetal Macrosomia | 1 | 2014 | 20 | 0.120 |
Why?
| Gravidity | 1 | 2013 | 5 | 0.110 |
Why?
| Rural Health | 1 | 2014 | 87 | 0.110 |
Why?
| Risk-Taking | 1 | 2014 | 109 | 0.110 |
Why?
| Veterans Health | 2 | 2024 | 62 | 0.110 |
Why?
| Referral and Consultation | 2 | 2012 | 285 | 0.110 |
Why?
| Treatment Outcome | 3 | 2020 | 5141 | 0.110 |
Why?
| Public Health | 1 | 2015 | 204 | 0.110 |
Why?
| Vitamins | 2 | 2023 | 64 | 0.110 |
Why?
| Risk Factors | 4 | 2018 | 3613 | 0.110 |
Why?
| Vitamin D | 2 | 2023 | 88 | 0.100 |
Why?
| Sleep | 2 | 2024 | 184 | 0.100 |
Why?
| Selection Bias | 1 | 2012 | 16 | 0.100 |
Why?
| Urination | 1 | 2011 | 19 | 0.100 |
Why?
| Child | 5 | 2023 | 6847 | 0.100 |
Why?
| Alcohol-Related Disorders | 1 | 2012 | 44 | 0.100 |
Why?
| Osmolar Concentration | 1 | 2011 | 62 | 0.100 |
Why?
| Contraception, Postcoital | 1 | 2011 | 8 | 0.100 |
Why?
| Computer Simulation | 1 | 2012 | 280 | 0.100 |
Why?
| Preceptorship | 1 | 2011 | 16 | 0.100 |
Why?
| Survivors | 1 | 2012 | 126 | 0.100 |
Why?
| Deglutition | 1 | 2011 | 42 | 0.100 |
Why?
| Substance Abuse Treatment Centers | 1 | 2011 | 76 | 0.100 |
Why?
| Oligonucleotide Array Sequence Analysis | 1 | 2012 | 411 | 0.100 |
Why?
| Quality Improvement | 2 | 2024 | 208 | 0.100 |
Why?
| Energy Metabolism | 1 | 2013 | 282 | 0.100 |
Why?
| Risk | 1 | 2012 | 320 | 0.100 |
Why?
| Infant, Premature | 1 | 2014 | 318 | 0.090 |
Why?
| Health Services Needs and Demand | 1 | 2012 | 158 | 0.090 |
Why?
| Models, Statistical | 1 | 2012 | 224 | 0.090 |
Why?
| Program Evaluation | 3 | 2019 | 354 | 0.090 |
Why?
| Career Choice | 1 | 2011 | 111 | 0.090 |
Why?
| Pharmacy | 1 | 2011 | 58 | 0.090 |
Why?
| Skin Neoplasms | 2 | 2008 | 488 | 0.090 |
Why?
| Linear Models | 2 | 2021 | 280 | 0.090 |
Why?
| Gene Expression | 1 | 2012 | 609 | 0.090 |
Why?
| Motivation | 1 | 2012 | 273 | 0.090 |
Why?
| Methods | 1 | 2009 | 55 | 0.080 |
Why?
| Color | 1 | 2009 | 22 | 0.080 |
Why?
| Head and Neck Neoplasms | 1 | 2012 | 268 | 0.080 |
Why?
| Central Nervous System Stimulants | 1 | 2011 | 213 | 0.080 |
Why?
| Reproducibility of Results | 3 | 2021 | 1193 | 0.080 |
Why?
| Clinical Competence | 2 | 2022 | 393 | 0.080 |
Why?
| Patient Education as Topic | 1 | 2011 | 302 | 0.080 |
Why?
| Parity | 2 | 2020 | 50 | 0.080 |
Why?
| Lung | 1 | 2011 | 486 | 0.080 |
Why?
| Gene Expression Profiling | 1 | 2012 | 1032 | 0.080 |
Why?
| Keratinocytes | 1 | 2008 | 90 | 0.070 |
Why?
| Precancerous Conditions | 1 | 2008 | 83 | 0.070 |
Why?
| Injections, Intra-Articular | 2 | 2017 | 33 | 0.070 |
Why?
| Carcinoma in Situ | 1 | 2008 | 73 | 0.070 |
Why?
| Prognosis | 1 | 2012 | 1942 | 0.070 |
Why?
| Fatty Acids, Omega-3 | 1 | 2007 | 28 | 0.070 |
Why?
| Arteriovenous Shunt, Surgical | 1 | 2007 | 29 | 0.070 |
Why?
| Orthopedic Procedures | 2 | 2017 | 68 | 0.070 |
Why?
| Social Work | 2 | 2017 | 25 | 0.070 |
Why?
| Knee Joint | 2 | 2017 | 162 | 0.070 |
Why?
| Epigenesis, Genetic | 1 | 2009 | 374 | 0.070 |
Why?
| Severity of Illness Index | 2 | 2023 | 945 | 0.060 |
Why?
| Carcinoma, Squamous Cell | 1 | 2008 | 318 | 0.060 |
Why?
| Regression Analysis | 2 | 2018 | 395 | 0.060 |
Why?
| Mississippi | 2 | 2015 | 88 | 0.060 |
Why?
| Health Services Research | 2 | 2019 | 150 | 0.060 |
Why?
| Cholecalciferol | 1 | 2023 | 23 | 0.060 |
Why?
| Thrombosis | 1 | 2007 | 248 | 0.060 |
Why?
| Dietary Supplements | 2 | 2023 | 443 | 0.060 |
Why?
| Pregnancy Trimester, Third | 2 | 2014 | 65 | 0.060 |
Why?
| Vaccines, DNA | 1 | 2003 | 11 | 0.060 |
Why?
| Educational Status | 2 | 2017 | 222 | 0.060 |
Why?
| Morbidity | 1 | 2023 | 133 | 0.050 |
Why?
| Patient-Centered Care | 1 | 2024 | 129 | 0.050 |
Why?
| Self Report | 2 | 2015 | 196 | 0.050 |
Why?
| Obesity | 2 | 2022 | 1113 | 0.050 |
Why?
| Practice Guidelines as Topic | 2 | 2017 | 449 | 0.050 |
Why?
| Plasmids | 1 | 2003 | 161 | 0.050 |
Why?
| Fetal Death | 1 | 2022 | 23 | 0.050 |
Why?
| Autopsy | 1 | 2022 | 46 | 0.050 |
Why?
| Interviews as Topic | 2 | 2015 | 259 | 0.050 |
Why?
| Narcotics | 1 | 2023 | 111 | 0.050 |
Why?
| Cancer Vaccines | 1 | 2003 | 78 | 0.050 |
Why?
| Sample Size | 1 | 2022 | 37 | 0.050 |
Why?
| Multicenter Studies as Topic | 1 | 2022 | 84 | 0.050 |
Why?
| Eating | 1 | 2023 | 162 | 0.050 |
Why?
| Breast Feeding | 1 | 2024 | 187 | 0.050 |
Why?
| Decision Making | 1 | 2024 | 265 | 0.050 |
Why?
| Republic of Korea | 1 | 2022 | 55 | 0.050 |
Why?
| Uterine Hemorrhage | 1 | 2021 | 11 | 0.050 |
Why?
| Comorbidity | 1 | 2023 | 615 | 0.050 |
Why?
| Academic Medical Centers | 2 | 2012 | 144 | 0.050 |
Why?
| Health Care Costs | 1 | 2022 | 170 | 0.050 |
Why?
| Suicidal Ideation | 1 | 2022 | 96 | 0.050 |
Why?
| Self Care | 1 | 2022 | 136 | 0.050 |
Why?
| Prenatal Diagnosis | 1 | 2021 | 107 | 0.050 |
Why?
| Emergencies | 1 | 2021 | 86 | 0.050 |
Why?
| Vaccination | 1 | 2022 | 266 | 0.050 |
Why?
| Prevalence | 1 | 2023 | 944 | 0.050 |
Why?
| Drug Administration Schedule | 1 | 2021 | 376 | 0.040 |
Why?
| Symptom Assessment | 1 | 2020 | 33 | 0.040 |
Why?
| Melanoma | 1 | 2003 | 285 | 0.040 |
Why?
| Drug Therapy, Combination | 1 | 2021 | 377 | 0.040 |
Why?
| Triage | 1 | 2020 | 62 | 0.040 |
Why?
| Weight Loss | 1 | 2021 | 237 | 0.040 |
Why?
| Erythroid Precursor Cells | 1 | 2019 | 15 | 0.040 |
Why?
| Crack Cocaine | 1 | 2019 | 17 | 0.040 |
Why?
| Forecasting | 1 | 2020 | 150 | 0.040 |
Why?
| Ohio | 1 | 2019 | 40 | 0.040 |
Why?
| Kentucky | 1 | 2019 | 47 | 0.040 |
Why?
| Prenatal Care | 1 | 2020 | 108 | 0.040 |
Why?
| Case-Control Studies | 1 | 2022 | 1131 | 0.040 |
Why?
| Combined Modality Therapy | 1 | 2020 | 637 | 0.040 |
Why?
| Mice | 1 | 2009 | 5739 | 0.040 |
Why?
| Stroke Volume | 1 | 2019 | 116 | 0.040 |
Why?
| Education, Medical, Graduate | 1 | 2020 | 205 | 0.040 |
Why?
| Information Storage and Retrieval | 1 | 2019 | 60 | 0.040 |
Why?
| Uterus | 1 | 2019 | 94 | 0.040 |
Why?
| Postoperative Complications | 2 | 2017 | 984 | 0.040 |
Why?
| Ventricular Function, Left | 1 | 2019 | 154 | 0.040 |
Why?
| Community-Institutional Relations | 1 | 2018 | 46 | 0.040 |
Why?
| Southeastern United States | 1 | 2017 | 45 | 0.040 |
Why?
| Empathy | 1 | 2018 | 46 | 0.040 |
Why?
| Emergency Service, Hospital | 1 | 2022 | 486 | 0.040 |
Why?
| Pandemics | 1 | 2022 | 559 | 0.040 |
Why?
| Incidence | 1 | 2020 | 1003 | 0.040 |
Why?
| Pulse | 1 | 2017 | 14 | 0.040 |
Why?
| Molecular Weight | 1 | 2017 | 84 | 0.040 |
Why?
| Attitude to Computers | 1 | 2017 | 18 | 0.040 |
Why?
| Blood Pressure Monitoring, Ambulatory | 1 | 2017 | 35 | 0.040 |
Why?
| Cross-Over Studies | 1 | 2017 | 224 | 0.040 |
Why?
| Safe Sex | 1 | 2017 | 10 | 0.040 |
Why?
| Cultural Competency | 1 | 2017 | 57 | 0.040 |
Why?
| Community Health Services | 1 | 2017 | 101 | 0.040 |
Why?
| Telephone | 1 | 2017 | 70 | 0.040 |
Why?
| Mortality | 1 | 2017 | 99 | 0.040 |
Why?
| Sexually Transmitted Diseases | 1 | 2017 | 36 | 0.040 |
Why?
| Methamphetamine | 1 | 2019 | 200 | 0.030 |
Why?
| Diagnosis, Dual (Psychiatry) | 1 | 2016 | 41 | 0.030 |
Why?
| Follow-Up Studies | 2 | 2012 | 2182 | 0.030 |
Why?
| Income | 1 | 2017 | 99 | 0.030 |
Why?
| Disabled Children | 1 | 2017 | 63 | 0.030 |
Why?
| Chi-Square Distribution | 1 | 2017 | 280 | 0.030 |
Why?
| Curriculum | 1 | 2019 | 401 | 0.030 |
Why?
| Virginia | 1 | 2015 | 17 | 0.030 |
Why?
| Qualitative Research | 1 | 2018 | 329 | 0.030 |
Why?
| Health Priorities | 1 | 2015 | 19 | 0.030 |
Why?
| Chorioamnionitis | 1 | 2015 | 15 | 0.030 |
Why?
| Puerperal Disorders | 1 | 2015 | 28 | 0.030 |
Why?
| Racism | 1 | 2017 | 60 | 0.030 |
Why?
| Back Pain | 1 | 2015 | 39 | 0.030 |
Why?
| Unsafe Sex | 1 | 2015 | 26 | 0.030 |
Why?
| Poverty | 1 | 2017 | 201 | 0.030 |
Why?
| Sensitivity and Specificity | 1 | 2017 | 861 | 0.030 |
Why?
| Biophysical Phenomena | 1 | 2014 | 19 | 0.030 |
Why?
| Blood Pressure | 1 | 2017 | 512 | 0.030 |
Why?
| Health Surveys | 1 | 2015 | 232 | 0.030 |
Why?
| Oxygen | 1 | 2017 | 326 | 0.030 |
Why?
| Patient Compliance | 1 | 2015 | 230 | 0.030 |
Why?
| Pregnancy Trimester, Second | 1 | 2013 | 27 | 0.030 |
Why?
| Animals | 1 | 2009 | 13187 | 0.030 |
Why?
| Exercise | 1 | 2018 | 495 | 0.030 |
Why?
| Health Status | 1 | 2015 | 298 | 0.030 |
Why?
| Marijuana Abuse | 1 | 2015 | 147 | 0.030 |
Why?
| Trismus | 1 | 2012 | 3 | 0.030 |
Why?
| Multivariate Analysis | 1 | 2014 | 577 | 0.030 |
Why?
| Radiotherapy, Adjuvant | 1 | 2012 | 56 | 0.030 |
Why?
| Ultrasonography | 1 | 2014 | 436 | 0.030 |
Why?
| Chemoradiotherapy | 1 | 2012 | 40 | 0.030 |
Why?
| Least-Squares Analysis | 1 | 2011 | 43 | 0.030 |
Why?
| Enteral Nutrition | 1 | 2012 | 147 | 0.020 |
Why?
| Deglutition Disorders | 1 | 2012 | 77 | 0.020 |
Why?
| Urban Population | 1 | 2012 | 151 | 0.020 |
Why?
| Carcinoma | 1 | 2012 | 138 | 0.020 |
Why?
| Pharmaceutical Services | 1 | 2011 | 55 | 0.020 |
Why?
| Weight Gain | 1 | 2012 | 240 | 0.020 |
Why?
| Students, Pharmacy | 1 | 2011 | 121 | 0.020 |
Why?
| Socioeconomic Factors | 1 | 2011 | 581 | 0.020 |
Why?
| Child, Preschool | 1 | 2017 | 3871 | 0.020 |
Why?
| Patient Acceptance of Health Care | 1 | 2011 | 329 | 0.020 |
Why?
| Observer Variation | 1 | 2008 | 130 | 0.020 |
Why?
| Age Factors | 1 | 2011 | 1087 | 0.020 |
Why?
| Cell Nucleus | 1 | 2008 | 183 | 0.020 |
Why?
| Polytetrafluoroethylene | 1 | 2007 | 32 | 0.020 |
Why?
| Vascular Patency | 1 | 2007 | 82 | 0.020 |
Why?
| Biocompatible Materials | 1 | 2007 | 69 | 0.020 |
Why?
| Double-Blind Method | 1 | 2007 | 681 | 0.020 |
Why?
| Lymphatic Metastasis | 1 | 2003 | 224 | 0.010 |
Why?
| Survival Analysis | 1 | 2003 | 653 | 0.010 |
Why?
| Flow Cytometry | 1 | 2003 | 476 | 0.010 |
Why?
|
|
Ounpraseuth's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|